“Clinician- and Patient-Reported Outcomes With Tirbanibulin 1% Treatment for Actinic Keratosis in Routine Clinical Practice Across the U.S. (PROAK Study)”. SKIN The Journal of Cutaneous Medicine 7, no. 3 (May 20, 2023): 771–787. Accessed June 15, 2025. https://skin.dermsquared.com/skin/article/view/2140.